Patrick K. Reville

Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial

Tapan M. Kadia, Patrick K. Reville, Gautam Borthakur et al. · The Lancet Haematology · 2021 · 175 citations · Full text

Medicine, Hematology, Oncology +16

Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy

Hussein A. Abbas, Dapeng Hao, Katarzyna Tomczak et al. · Nature Communications · 2021 · 130 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Tapan M. Kadia, Patrick K. Reville, Xuemei Wang et al. · Journal of Clinical Oncology · 2022 · 114 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Consumption of Soy Isoflavone Enriched Bread in Men with Prostate Cancer Is Associated with Reduced Proinflammatory Cytokines and Immunosuppressive Cells

Gregory B. Lesinski, Patrick K. Reville, Thomas A. Mace et al. · Cancer Prevention Research · 2015 · 83 citations · Full text

Medicine, Nutritional Sciences, Oncology +17

Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies

Bofei Wang, Patrick K. Reville, Mhd Yousuf Yassouf et al. · Nature Communications · 2024 · 66 citations · Full text

Life Sciences, Hematology, Immunology +17